ABSTRACT
Macrolide monotherapy is currently recommended as first-line treatment of mild-to-moderate community-acquired pneumonia (CAP) in penicillin-intolerant/allergic individuals in the UK. However, resistance rates among the commonest cause, Streptococcus pneumoniae, now exceed 10% in the UK and a review of alternative agents is therefore timely. This review considers the relative merits of two agents, doxycycline and moxifloxacin, which are candidates to replace macrolides for second-line therapy of non-severe CAP.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Aza Compounds/therapeutic use , Community-Acquired Infections/drug therapy , Doxycycline/therapeutic use , Pneumonia, Bacterial/drug therapy , Quinolines/therapeutic use , Clinical Trials as Topic , Community-Acquired Infections/microbiology , Fluoroquinolones , Humans , Moxifloxacin , Pneumonia, Bacterial/microbiology , Treatment Outcome , United KingdomABSTRACT
Over the past decade, non-fermenting Gram-negative bacteria have emerged as important opportunistic pathogens in the increasing population of patients who are immunocompromised by their disease or medical treatment. These bacteria are assisted by their ubiquitous distribution in the environment and have a propensity for multiple, intrinsic or acquired drug resistance. The infections that they cause now pose significant problems in terms of treatment and infection control, whilst the commonly observed rapid emergence of bacterial resistance to new antimicrobial compounds raises concerns regarding the clinical lifespan of these agents. Studies are urgently required to assess whether combination therapy can improve the long-term utility of new drugs in the treatment of patients infected with non-fermenters.
Subject(s)
Fermentation , Gram-Negative Bacteria/drug effects , Gram-Negative Bacteria/metabolism , Gram-Negative Bacterial Infections/drug therapy , Gram-Negative Bacterial Infections/microbiology , Drug Resistance, Bacterial , Gram-Negative Bacteria/isolation & purification , Gram-Negative Bacteria/physiology , Gram-Negative Bacterial Infections/epidemiology , HumansABSTRACT
Fungi are increasingly recognised as major pathogens in critically ill patients. Candida spp. and Cryptococcus spp. are the yeasts most frequently isolated in clinical practice. The most frequent filamentous fungi (moulds) isolated are Aspergillus spp., but Fusarium spp., Scedosporium spp., Penicillium spp., and Zygomycetes are increasingly seen. Several reasons have been proposed for the increase in invasive fungal infections, including the use of antineoplastic and immunosuppressive agents, broad-spectrum antibiotics, and prosthetic devices and grafts, and more aggressive surgery. Patients with burns, neutropenia, HIV infection and pancreatitis are also predisposed to fungal infection. The epidemiology and clinical features of fungal infections are reviewed, together with antifungal agents currently or soon to be available.
Subject(s)
Antifungal Agents/therapeutic use , Mycoses/drug therapy , Mycoses/epidemiology , HumansABSTRACT
We describe an apparent outbreak of respiratory infection with Acinetobacter species involving 14 patients over 8 days. Epidemiological investigation revealed two consecutive pseudo-outbreaks of infection caused by two consecutive, unrelated laboratory errors in the processing of sputum, nasopharyngeal, and endotracheal aspirates.
Subject(s)
Acinetobacter Infections/transmission , Acinetobacter/isolation & purification , Cross Infection/transmission , Respiratory Tract Infections/transmission , Specimen Handling , Acinetobacter Infections/epidemiology , Clinical Laboratory Techniques/instrumentation , Cross Infection/epidemiology , Electrophoresis, Gel, Pulsed-Field , Equipment Contamination , Humans , Respiratory Tract Infections/epidemiologyABSTRACT
A typing scheme was devised for an epidemiological study of infection with coagulase-negative staphylococci in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). The scheme was constructed in four stages suitable for the screening of large numbers of isolates: antibiogram, biotype, phage type, and plasmid profile. The discrimination and reproducibility of the scheme was established by the examination of 50 isolates from 33 consecutive episodes of peritonitis affecting 18 patients. The discrimination of the scheme was 76%, with a reproducibility of 86%. Indistinguishable strains occurred in individual patients only, demonstrating that no cross-infection between patients occurred during the 10-month period of collection of strains, and suggesting that the discriminating power of the scheme was, in fact, much higher. The antibiogram, selected as the first stage of the scheme because it was the simplest and cheapest test, proved to be the most discriminatory stage, providing 60% of the final discriminatory power.
Subject(s)
Bacterial Typing Techniques , Peritonitis/microbiology , Staphylococcal Infections/microbiology , Staphylococcus/classification , Anti-Bacterial Agents/pharmacology , Bacteriophage Typing , Coagulase/analysis , Humans , Microbial Sensitivity Tests , Peritoneal Dialysis, Continuous Ambulatory , Plasmids , Species Specificity , Staphylococcal Infections/epidemiology , Staphylococcus/drug effects , Staphylococcus/isolation & purification , Staphylococcus/metabolismABSTRACT
The fibronectin-binding proteins of Staphylococcus aureus are considered to be important virulence factors for colonisation and infection. The polymerase chain reaction (PCR) was used to detect part of a gene equivalent to the fbnA gene of S. aureus in 120 isolates of staphylococci (S. aureus, S. epidermidis, S. haemolyticus, S. simulans, S. hominis, S. warneri, S. cohnii and S. lugdunensis). Primers specific for the binding domain region of the fbnA gene of S. aureus produced PCR products of the predicted sizes (93 and 207 bp). The identity of the PCR products was confirmed by digestion with DdeI and nucleic acid hybridisation. The fibronectin-binding activity of the staphylococci was determined with a particle agglutination assay (PAA). The fbn gene was found to be present by PCR in 107 of the 120 staphylococci tested, irrespective of their site of isolation, and expression of the gene was detected by PAA in 101 of the 120 strains.
Subject(s)
Adhesins, Bacterial , Bacterial Outer Membrane Proteins/genetics , Bacterial Proteins , Carrier Proteins , Staphylococcal Infections/microbiology , Staphylococcus aureus/genetics , Staphylococcus/genetics , Agglutination Tests , Base Sequence , Blotting, Southern , DNA Primers/chemistry , DNA, Bacterial/chemistry , Endocarditis, Bacterial/microbiology , Genes, Bacterial , Humans , Molecular Sequence Data , Peritoneal Dialysis, Continuous Ambulatory , Peritonitis/microbiology , Polymerase Chain Reaction , Skin/microbiology , Staphylococcus/isolation & purification , Staphylococcus/pathogenicity , Staphylococcus aureus/isolation & purification , Staphylococcus aureus/pathogenicity , Virulence/geneticsABSTRACT
The epidemiology of 10 episodes of CAPD peritonitis caused by coagulase-negative staphylococci was studied. The infecting micro-organism was found in prospective skin swabs in six episodes, widely distributed and as the predominant, or equally predominant, organism at each site but was not detected in swabs taken more than 12 weeks before the episode of peritonitis; this suggests recent acquisition. Infecting strains were no more likely to be adherent or to produce slime than non-infecting strains, nor had they any other characteristic detected in our typing scheme that might lead to their detection before peritonitis developed.
Subject(s)
Peritoneal Dialysis, Continuous Ambulatory , Peritonitis/epidemiology , Skin/microbiology , Staphylococcal Infections/epidemiology , Staphylococcus/isolation & purification , Bacterial Adhesion , Coagulase/analysis , Drug Resistance, Microbial , Female , Humans , Male , Peritonitis/microbiology , Species Specificity , Staphylococcal Infections/microbiology , Staphylococcus/classification , Staphylococcus/physiology , Staphylococcus epidermidis/classification , Staphylococcus epidermidis/isolation & purification , Staphylococcus epidermidis/physiologyABSTRACT
The peritoneal cavity of patients undergoing CAPD is critically immunocompromised and infectious peritonitis is the most important complication of the technique. Nevertheless, recent research into the epidemiology and pathogenesis of infections caused by the most important microorganisms has enabled significant reductions in peritonitis rates to be made. Peritonitis caused by Staphylococcus aureus and Pseudomonas aeruginosa can be prevented by eliminating their principal source, an infected Tenckhoff catheter wound. The source of infection for coagulase-negative staphylococci and other pseudomonads cannot be eliminated, but peritonitis caused by these organisms may be prevented by interrupting their routes of entry into the peritoneal cavity. The identification of host factors predictive of enhanced susceptibility to infectious peritonitis offers the further possibility of prevention by immunological approaches. Although the main difficulties surrounding the diagnosis of infective peritonitis have been clarified, approximately 20% of episodes remain culture-negative, with multifactorial aetiology. Initial (empirical) combination antibiotic therapy can be both appropriate and effective in approximately 85% of cases. Intraperitoneal monotherapy with fluoroquinolones has been equally successful, and these agents may prove effective by the oral route, offering considerable advantages in cost and convenience. Approximately 5% of episodes of bacterial peritonitis are unresponsive to antibiotic therapy. These cases may be conveniently managed by the technique of Tenckhoff catheter removal and replacement at a single operation.
Subject(s)
Cross Infection/epidemiology , Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Peritonitis/epidemiology , Administration, Oral , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Catheters, Indwelling , Cross Infection/microbiology , Cross Infection/therapy , Drug Resistance, Microbial , Hospitals, University , Humans , Injections, Intraperitoneal , London/epidemiology , Peritonitis/microbiology , Peritonitis/therapy , Predictive Value of Tests , Prevalence , Risk FactorsABSTRACT
We describe the control of wound infection with Staphylococcus aureus in patients undergoing continuous ambulatory peritoneal dialysis at St. Thomas' Hospital. Forty-nine percent of 61 catheters inserted in 1985 and 1986 became infected, and the majority of these infections were acquired in hospital. Infection was impossible to eradicate and was frequently associated with the subsequent development of S. aureus peritonitis, which was the most important cause of catheter loss. Strict adherence to aseptic techniques for catheter insertion and care, combined with eradication of S. aureus carriage, reduced the infection rate to 12% for the 50 catheters inserted in 1987, abolished hospital-acquired infection and reduced the S. aureus peritonitis rate tenfold, without the use of prophylactic antibiotics. S. aureus infection is a serious but avoidable complication of continuous ambulatory peritoneal dialysis.
Subject(s)
Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Peritonitis/prevention & control , Staphylococcal Infections/prevention & control , Anti-Infective Agents, Local/therapeutic use , Asepsis/methods , Catheters, Indwelling/adverse effects , Chlorhexidine/therapeutic use , Cross Infection/prevention & control , Female , Floxacillin/administration & dosage , Floxacillin/therapeutic use , Humans , Male , Occlusive Dressings , Peritonitis/etiology , Vancomycin/administration & dosage , Vancomycin/therapeutic use , Wound Infection/prevention & controlABSTRACT
The major complication of central venous catheterization for immediate access for haemodialysis is infection. The Quinton Permcath is a tunnelled, double lumen, flexible silastic catheter with a Dacron cuff, and is claimed to be associated with a low rate of infection. In a two-year study we have monitored all complications including catheter-associated infection related to this device in haemodialysis patients while following a simple aseptic programme for the care of the catheter exit wound. Thirty four Permcaths were inserted in 30 patients for a mean duration of 6.2 months (SD +/- 5.7; range 2 days to 23 months). Catheter use amounted to a total of 197 months. Of twenty-seven catheter wound infections, 6 (22%) were caused by Staphylococcus aureus, and 15 (56%) by coagulase-negative staphylococci or corynebacteria. These occurred in 19 patients, giving an exit site infection rate of one episode per 7.4 catheter months. Catheter-associated septicaemia occurred in three patients (two S. aureus, one S. epidermidis), at a rate of one episode per 66 months. It was possible to correlate three episodes of infection with breakdown in aseptic care. This study confirms the low rate of infection associated with the use of the Permcath, and we conclude that the design of the device and aseptic care of the catheter and its wound contribute to this.
Subject(s)
Bacterial Infections/epidemiology , Catheters, Indwelling/adverse effects , Cross Infection/epidemiology , Renal Dialysis/instrumentation , Adult , Aged , Aged, 80 and over , Asepsis/standards , Bacterial Infections/etiology , Bacterial Infections/microbiology , Clinical Protocols/standards , Cross Infection/etiology , Cross Infection/microbiology , Equipment Design , Evaluation Studies as Topic , Hospitals, University , Humans , London/epidemiology , Middle Aged , Risk FactorsABSTRACT
In 1987 a preventive programme was initiated to address the problem of high hospital and community-acquired CAPD infection. It concentrated on reducing Staphylococcus aureus carriage, improving aseptic operative technique, intensive training for nursing staff and patients in stringent aseptic care of the exit site, and avoidance of contact of the exit site with unsterile water. This programme was associated with an overall 10-fold reduction in exit site infection, a 2-fold reduction in peritonitis, and a 4.5-fold reduction in catheter loss from infection. These reductions have been sustained. Preventing infection in CAPD patients requires persistence and commitment but improves the patient's quality of life and reduces the cost of treatment.
Subject(s)
Bacterial Infections/prevention & control , Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Asepsis , Bacterial Infections/etiology , Catheterization/adverse effects , Catheterization/methods , Humans , Infection Control , Peritoneal Dialysis, Continuous Ambulatory/methods , Peritonitis/etiology , Peritonitis/prevention & control , Preoperative CareABSTRACT
A real-time TaqMan multiplex polymerase chain reaction (PCR) assay was developed to detect genes encoding five types of serine carbapenemases (GES, IMI/NMC, KPC, OXA-48 and SME). The assay was validated using control strains known to produce each of these types of enzyme and was then further assessed by 'blindly' testing 59 previously characterised clinical isolates, including 19 with serine (KPC or OXA-48) carbapenemases, 22 with metallo- (IMP, VIM or NDM) carbapenemases, and 18 with carbapenem resistance contingent upon extended-spectrum ß-lactamase (ESBL) or AmpC production combined with porin loss. The assay detected and correctly assigned the serine carbapenemases in all five positive control strains and in 19 clinical isolates. No false-positive results were seen for isolates with metallo-enzymes or for those that lacked a carbapenemase. The five serine carbapenemase genotypes could also be distinguished by melt-curve analysis or the molecular size of the amplicons.
Subject(s)
Bacterial Proteins/genetics , Enterobacteriaceae/enzymology , Enterobacteriaceae/genetics , Polymerase Chain Reaction/methods , beta-Lactam Resistance/genetics , beta-Lactamases/genetics , Anti-Bacterial Agents/pharmacology , Carbapenems/pharmacology , Chromatography, Gel , DNA Primers , Enterobacteriaceae/drug effects , Enterobacteriaceae/isolation & purification , Enterobacteriaceae Infections/microbiology , Humans , Microbial Sensitivity Tests , Taq Polymerase , Time Factors , Transition Temperature , beta-Lactams/pharmacologySubject(s)
Hand/microbiology , Health Personnel , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Staphylococcal Infections/microbiology , Staphylococcal Infections/transmission , Bacterial Typing Techniques , Bacteriophage Typing , DNA Fingerprinting , Electrophoresis, Gel, Pulsed-Field , Hospitals, Teaching , Humans , Methicillin-Resistant Staphylococcus aureus/classification , Molecular Epidemiology , United KingdomABSTRACT
The clinical course and laboratory diagnosis of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis was studied in 32 consecutive episodes. Peritonitis was associated with a failure in aseptic technique in eight episodes and with an exit-site infection in four episodes. Intraperitoneal vancomycin and ceftazidime were safe, effective, and convenient. Most patients administered their antibiotics at home, and symptoms usually resolved by day 4. Culture of the deposit obtained by centrifugation of 50 ml of effluent after leukocyte lysis provided the best rate of recovery (84% culture positive) but was technically demanding. Filtration of the same volume without leukocyte lysis was simple to perform and almost as effective. Enrichment was less satisfactory (65% culture positive) owing to the presence of antibiotic or infection with fastidious microorganisms. Culture of 50 ml of effluent after concentration by a commonly used laboratory technique, centrifugation without leukocyte lysis, performed poorly (59% culture positive at 48 h), as this method caused sequestration and death of microorganisms within the leukocytes. Culture of nearly 1 liter of effluent from 33 asymptomatic patients by the same techniques yielded no microorganisms.
Subject(s)
Bacterial Infections/diagnosis , Peritoneal Dialysis, Continuous Ambulatory , Peritonitis/diagnosis , Bacteria/growth & development , Bacteria/isolation & purification , Colony Count, Microbial , Gentian Violet , Humans , Leukocyte Count , PhenazinesABSTRACT
Ciprofloxacin was evaluated as single-agent therapy for the empirical treatment of patients presenting with CAPD peritonitis in an open, uncontrolled trial. Seventy-five episodes of peritonitis in 44 patients receiving continuous ambulatory peritoneal dialysis were entered in the study. The antibiotic was administered intraperitoneally, at a dose of 50 mg/l in each bag of dialysate, for seven days. Treatment with ciprofloxacin was appropriate (organisms isolated sensitive to ciprofloxacin) and successful (clinical and bacteriological cure of peritonitis) in 62 (83%) of the 75 episodes. The mean ciprofloxacin concentrations in serum and effluent were 1.1 mg/l (range 0-2.9 mg/l) and 10.0 mg/l (range 0.2-33.4 mg/l), respectively, with no evidence of accumulation. Side effects were seen in two patients only, and were mild and transitory.
Subject(s)
Ciprofloxacin/therapeutic use , Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Peritonitis/drug therapy , Adult , Ciprofloxacin/adverse effects , Clinical Trials as Topic , Dialysis Solutions , Humans , Microbial Sensitivity Tests , Peritonitis/etiologyABSTRACT
The preservation of micro-organisms that may be found on the skin was studied by storage in liquid media at--70 degrees C. In the first part of the study the performance of 12 varieties of suspending media was evaluated with pure cultures of 17 species of micro-organisms maintained in the laboratory. After storage for 1 year the best medium (Oxoid Nutrient Broth with 15% glycerol) showed a mean survival for all organisms studied of 83.8%, with no significant differences between organisms. Even the worst medium (distilled water) permitted greater than 40% survival at 1 year. No changes in the characteristics of these micro-organisms were detected after 6 months storage in glycerol broth. In the second part of the study nose swabs were suspended in one representative medium (Bacto Nutrient Broth containing 7% glycerol). The mean percentage survival of staphylococci in these suspensions after 1 year's storage at - 70 degrees C was 75.4%. These results indicate that coagulase-negative coagulase-negative staphylococci in samples of skin flora may be stored under these conditions for long periods, greatly reducing the work-load in epidemiological studies of infection.
Subject(s)
Cryopreservation , Nasal Mucosa/microbiology , Skin/microbiology , Staphylococcus/growth & development , Culture Media , Humans , Regression AnalysisABSTRACT
A transferable 55-MDa plasmid which encoded resistance to both vancomycin and high concentrations of gentamicin was identified in a clinical isolate of Enterococcus faecalis. The plasmid hybridized with probes for the vanB and aac6'aph2" resistance genes. This is the first report of linkage of glycopeptide and high-level aminoglycoside resistance genes in an Enterococcus sp.
Subject(s)
Enterococcus faecalis/drug effects , Enterococcus faecalis/genetics , Gentamicins/pharmacology , Plasmids/genetics , Vancomycin/pharmacology , Base Sequence , Conjugation, Genetic , DNA, Bacterial/metabolism , Drug Resistance, Microbial/genetics , Gram-Positive Bacterial Infections/microbiology , Humans , Molecular Sequence Data , Nucleic Acid HybridizationABSTRACT
A man with Paget's disease of bone was admitted with a fractured neck of femur. On admission he was normocalcaemic, but with immobilization he rapidly became hypercalcaemic, despite a normal diet and no medication. The hypercalcaemia responded to calcitonin. Although hypercalcaemia is often quoted as complicating the immobilization of such patients, well documented uncomplicated cases have rarely been reported.